Proactive news headlines including Elon Musk, Vuzix, Context Therapeutics and American Manganese

12/3/2021, 7:11 PM (Source: GlobeNewswire)

New York , Dec. 03, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

  • Vuzix signs distribution agreement with Austrian firm, receives initial Smart Glasses order click here
  • Elon Musk sells US$1bn worth of Tesla shares after exercising further options click here
  • Revive Therapeutics expands research with Bucillamine as potential treatment for Omicron variant click here
  • Great Atlantic Resources intersects high-grade quartz veins and visible gold at its Golden Promise project in Newfoundland click here
  • Harbor Custom Development acquires 438-acre master planned community near Vancouver, B.C. for $14M click here
  • LexaGene closes multiple MiQLab sales as it makes good progress in sales cycle click here
  • KetamineOne subsidiary KGK Science helps its client Hofseth Biocare receive New Dietary Ingredient status from US FDA click here
  • American Manganese poised to strengthen its global patent portfolio with latest filing click here
  • Context Therapeutics reports 3Q results during a “pivotal” period for the company click here


About Proactive

  • Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle.
  • With six offices on three continents, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives to engage intelligently with investors.
  • In 2020, Proactive featured in 809 million search results, our content was viewed over 165 million times and our readers spent over 10 million hours on our websites. Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.

For more information on how Proactive can help you make a difference, email us at

Primary Logo

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.